GI Dysmotility Symptoms Are Not Associated With Increased L-Dopa Requirements in Parkinson's Disease Patients

被引：0
|
作者：
Chang, Jocelyn [1 ]
Gadi, Sanjay [2 ]
Kuo, Braden [3 ]
Pasricha, Trisha S. [3 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1548
引用
收藏
页码：S1107 / S1108
页数：2
相关论文
共 50 条
  • [1] Disease progression and increased L-dopa efficacy with time in Parkinson's disease
    Holford, NHG
    Chan, PLS
    Lee, YY
    Nutt, JG
    MOVEMENT DISORDERS, 2002, 17 : S112 - S112
  • [2] The effects of L-Dopa on attention in Parkinson's disease and Parkinson's dementia patients
    Molloy, S
    McKeith, IG
    Burn, D
    Wesnes, KA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A51 - A51
  • [3] The effects of L-dopa on attention in Parkinson's disease and Parkinson's dementia patients
    Molloy, S.
    McKeith, I. G.
    Burn, D.
    Wesnes, K. A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 294 - 294
  • [4] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [5] The Effect of L-dopa on Postural Stability in Parkinson's Disease Patients
    Wilczynski, Jacek
    Habik, Natalia
    APPLIED SCIENCES-BASEL, 2019, 9 (03):
  • [6] Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients
    O. Bartošová
    C. Bonnet
    O. Ulmanová
    M. Šíma
    F. Perlík
    E. Růžička
    O. Slanař
    Journal of Neural Transmission, 2018, 125 : 699 - 703
  • [7] Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients
    Bartosova, O.
    Bonnet, C.
    Ulmanova, O.
    Sima, M.
    Perlik, F.
    Ruzicka, E.
    Slanar, O.
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (04) : 699 - 703
  • [8] L-dopa response following pallidotomy in patients with Parkinson's disease
    Levy, R
    Fine, J
    Dostrovsky, JO
    Lozano, AM
    Lang, AE
    NEUROLOGY, 2000, 54 (07) : A187 - A187
  • [9] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [10] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
12345